Monoclonal Antibodies
According to a new study published in the Proceedings of the National Academy of
The results of a pair of long-term survival studies indicate the therapeutic value of
Bexxar® (tositumomab and iodine I 131 ) is a radiolabled
Rituxan® is the brand marketing name of the monoclonal
Oncolym (131I Lym-1) is an Iodine 131 radiolabled
According to a recent randomized controlled trial, rituximab increased the duration of remission
Biopharmaceutical company MorphoSys is reporting that it has been given fast track
According to findings to be reported at the annual meeting of the American Society of Clinical
Pharmaceutical giant Pfizer is withdrawing the monoclonal antibody
Today the US Food and Drug Administration granted accelerated approval for Darzalex (
At the 17th Congress of the European Hematology Association (EHA), biopharmaceutical company
TG Therapeutics, Inc. announced today the U.S. Food and Drug Administration (FDA) has